GeneGuard
GeneGuard is a pioneering biotech startup, majority owned by WSC Holding Limited, focused on revolutionising healthcare with next-generation probiotics (NGPs).
Leveraging cutting-edge microbiology, genetic engineering and machine learning, we develop advanced probiotics to address critical unmet medical needs in both humans and animals.
Our team is dedicated to unlocking the nutraceutical and pharmaceutical potential of NGPs, offering innovative solutions for chronic and infectious diseases.
Our Vision
We aspire to utilise the untapped potential of next-generation probiotics to transform healthcare through expanding treatment options that include innovative, effective, and safer cost-effective engineered microbes with precision.
Our Mission
To revolutionise personal healthcare through cutting-edge recombinant probiotic live biotherapeutic product (LBP) therapies, offering new approaches and methodologies in the fight against chronic and infectious diseases.
Our Team
Our team is composed of world-class microbiobiologists, experienced bioinformatics experts, and successful entrepreneurs with a proven track record in startups. United by a shared vision, we're committed to driving innovation and breakthroughs in next-generation probiotics.
